FDA Grants Accelerated Approval to Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer

December 11, 2024
by saivisakanr@gmail.com

Share Article

https://www.drugs.com/newdrugs/fda-grants-accelerated-approval-bizengri-zenocutuzumab-zbco-nrg1-pancreatic-adenocarcinoma-nrg1-non-6413.html

You might also like

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

November 4, 2024

Mindfulness

Physical and Mental Benefits of meditation

Lorem ipsum dolor sit amet, consectet adipiscing elit, sed do eiusm por incididunt ut labore et dolore magna aliquat enim

November 4, 2024

#Mindey

@mindey